PharmaBlock Sciences (Nanjing), Inc. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 1,184.7 million compared to CNY 902.93 million a year ago. Revenue was CNY 1,184.7 million compared to CNY 902.93 million a year ago.

Net income was CNY 249.62 million compared to CNY 442.38 million a year ago. Basic earnings per share from continuing operations was CNY 1.257 compared to CNY 2.2399 a year ago. Diluted earnings per share from continuing operations was CNY 1.2501 compared to CNY 2.2152 a year ago.